Lithium Controlled-Release and Extended-Release Tablets and Vaqta Pediatric
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Vaqta Pediatric and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: hepatitis a pediatric vaccine
Brand name: Havrix Pediatric, Vaqta Pediatric
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Vardenafil
- Lithium Controlled-Release and Extended-Release Tablets-Vardenafil Hydrochloride
- Lithium Controlled-Release and Extended-Release Tablets-Vardenafil ODT
- Lithium Controlled-Release and Extended-Release Tablets-Vardenafil Orally Disintegrating Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Vardenafil Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Varenicline
- Vaqta Pediatric-Lithium ER
- Vaqta Pediatric-Lithium Oral Solution
- Vaqta Pediatric-Lithium Salts
- Vaqta Pediatric-Lithium Syrup and Oral Solution
- Vaqta Pediatric-Lithobid
- Vaqta Pediatric-Lithostat